NCT07446465 2026-03-03FOLFOX Chemotherapy Combined With Fruquintinib and Serplulimab as First-Line Conversion Therapy for Initially Unresectable pMMR/MSS Colorectal CancerFudan UniversityPhase 4 Not yet recruiting42 enrolled
NCT06562543 2026-02-27A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerTakedaPhase 4 Recruiting78 enrolled